Genelux CorporationGNLXNASDAQ

|||

Switch Symbol:

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 67% recommend buying.

Consensus Rating

Buy

3 analysts·Low coverage

67%

Rating Distribution

Strong Buy

00%

Buy

267%

Hold

133%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 617% higher.

Bear Case

$16.00

+562%

Consensus

$17.33

+617%

Bull Case

$20.00

+727%

Price Range3 analysts

Low

Consensus

High

$16.00

$20.00

Current Target

Current Price

$2.42

Upside to Target

$14.91

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-0.94(4 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+734.89%

EPS—

FY2028

Rev+312.05%

EPS—

FY2029

Rev+111.63%

EPS—

Earnings Surprises

Beat rate:33%(4/12 quarters)

Avg surprise:-34.4%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Oct 21, 2025Maxim Group

Genelux price target raised to $20 from $10 at Maxim

Target:$20.00

+199.9%from $6.67

Oct 21, 2025Lake Street

Genelux initiated with a Buy at Lake Street

Target:$16.00

+151.9%from $6.35

Oct 21, 2025Loop Capital Markets

Lake Street Capital Markets Starts Genelux Corp. (GNLX) at Buy

Target:$16.00

+151.9%from $6.35

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance